Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Clark JT, Smith ER (1986). „Failure of pimozide and metergoline to antagonize the RDS-127-induced facilitation of ejaculatory behavior”. Physiology & Behavior37 (1): 47–52. DOI:10.1016/0031-9384(86)90382-3. PMID3737722.
Sahin I, Tuncer M, Ilhan M (March 1990). „Dopamine receptor agonists, N,N-dipropyl-2-aminotetralin (TL-68) and 2-di-n-propylamino-4,7-dimethoxyindane (RDS-127) antagonize oxotremorine-induced tremors by antimuscarinic action in mice”. Archives Internationales De Physiologie et De Biochimie98 (1): 7–9. DOI:10.3109/13813459009115730. PMID1692697.
Arnerić SP, Roetker A, Long JP (September 1982). „Potent anorexic-like effects of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in the rat: a comparison with other dopamine-receptor agonists”. Neuropharmacology21 (9): 885–90. DOI:10.1016/0028-3908(82)90080-6. PMID6897285.
Arnerić SP, Roetker A, Long JP, Mott J, Barfknecht CF (June 1982). „Effects of semirigid methoxamine analogs on vascular smooth muscle: studies of methoxy-2-aminotetralin and 2-aminoindane derivatives”. Archives Internationales De Pharmacodynamie et De Thérapie257 (2): 263–73. PMID7114973.
Arnerić SP, Long JP (May 1984). „Evidence that a novel dopamine receptor agonist, RDS-127 [2-di-n-propylamino-4,7-dimethoxyindane] has some centrally mediated cardiovascular actions”. The Journal of Pharmacy and Pharmacology36 (5): 318–21. PMID6145768.
Clark JT, Smith ER (1986). „Failure of pimozide and metergoline to antagonize the RDS-127-induced facilitation of ejaculatory behavior”. Physiology & Behavior37 (1): 47–52. DOI:10.1016/0031-9384(86)90382-3. PMID3737722.
Rezaki YE, Ilhan M (1991). „Evaluation of alpha-adrenoceptor agonistic activity of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in rabbit and rat aortae”. Archives Internationales De Pharmacodynamie et De Thérapie310: 76–86. PMID1685313.
Sahin I, Ilhan M (1988). „The antimuscarinic activity of a dopamine receptor agonist (RDS-127) differentiates M2-muscarinic receptors of heart, ileum and trachea in guinea-pig”. Archives Internationales De Pharmacodynamie et De Thérapie296: 163–72. PMID2907277.
Sahin I, Tuncer M, Ilhan M (March 1990). „Dopamine receptor agonists, N,N-dipropyl-2-aminotetralin (TL-68) and 2-di-n-propylamino-4,7-dimethoxyindane (RDS-127) antagonize oxotremorine-induced tremors by antimuscarinic action in mice”. Archives Internationales De Physiologie et De Biochimie98 (1): 7–9. DOI:10.3109/13813459009115730. PMID1692697.
Arnerić SP, Roetker A, Long JP (September 1982). „Potent anorexic-like effects of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in the rat: a comparison with other dopamine-receptor agonists”. Neuropharmacology21 (9): 885–90. DOI:10.1016/0028-3908(82)90080-6. PMID6897285.